首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗HIV-1基因治疗新进展
引用本文:田雅茹,焦艳梅,张,彤,吴,昊.抗HIV-1基因治疗新进展[J].首都医学院学报,2014(1):101-107.
作者姓名:田雅茹  焦艳梅        
作者单位:首都医科大学附属北京佑安医院感染中心,北京100069
基金项目:"十二五"国家科技支撑计划重大项目(2012ZX10001-006);北京市艾滋病研究重点实验室(BZ0089).
摘    要:虽然高效抗反转录病毒治疗(highly active anti-retroviral therapy,HAART)取得了显著的成果,但是抗人类免疫缺陷病毒(human immunodeficiency virus,HIV)药物治疗仍有其局限性(如引起毒素蓄积和病毒突变).基因治疗在理论上具有较好的抗HIV能力,可以通过持续干扰病毒复制,提供了阻止HIV进行性感染的希望.本篇综述主要探讨当前多种基因治疗策略及其最新进展.

关 键 词:获得性免疫缺陷综合征  人类免疫缺陷病毒1型  基因疗法  慢病毒载体

Recent progress in the gene therapies against HIV-1
Tian Yaru,Jiao Yanmei,Zhang Tong,Wu Hao.Recent progress in the gene therapies against HIV-1[J].Journal of Capital University of Medical Sciences,2014(1):101-107.
Authors:Tian Yaru  Jiao Yanmei  Zhang Tong  Wu Hao
Institution:( Center oflnfectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China )
Abstract:Highly active antiretroviral therapy (HAART) has achieved significant success, but anti-HIV drug treatment still has its limitation, such as causing drug toxicity and viral-escape mutants. Gene therapy has better ability of anti-HIV in theory. It offers the promise of preventing progressive HIV infection by sustained interference with viral replication. Gene-targeting strategies are being developed with RNA-based agents, such as ribozyme, antisense, RNA aptamers and small interfering RNA, and protein-based agents, such as the mutant HIV Rev protein M10, fusion inhibitors and zinc-finger nucleases. This review mainly discusses the various gene therapy strategies and recent progress. Many of these strategies are being tested in ongoing and planned clinical trials.
Keywords:acquired immune deficiency syndrome (AIDS)  human immunodeficiency virus type I(HIV-1)  gene therapy  lentivector
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号